My Awards:

 


 

 


Mark your calendars now for July 31 - Aug. 2, 2008

 

4th Annual Napa Dental Experience

 

 

 

Join the ADHA today!

 

www.adha.org


Welcome to Amyrdh.com!

 

Please click on the sponsor banners.  The sponsors are allowing this site to continue as a FREE resource for all RDH's and DH Students!



 

Pharmocology
Chapter 5

Contributed by:

Mary Cassatt
University of Medicine and Dentistry of New Jersey

Disclaimer: These notes were copied and pasted from files sent to me by Mary.  They have not been reviewed for errors. You are responsible for checking out the information to verify the accuracy. This site, Amy Nieves, Ashley Quinn, Donna Lawson, and Mary Cassatt are not responsible for typographical errors.

Summary

 

Autonomic Nervous System- ANS

q       Controls smooth muscle

q       Cardiac muscle

q       Gland secretion

Affects

q       BP,

q       Heart Rate

q       GI Motility

q       Salivary secretions

q       Bronchial smooth muscle

 

Almost all body tissues are

q       Innervated by ANS

q       ANS = Modified by altering any events associated with

q       Neurotransmitters

q       (synthesis, storage, release, receptor, interaction and deposition)- re-uptake and breakdown

q       Either the receptor or neurotransmitter is effected

 

IMPORTANT TO DENTAL HYGIENE TREATMENT BECAUSE

q       ANS DRUGS ARE USED IN DENTISTRY

q       Produce adverse oral reactions

q       ( antidepressants and anticholingerics) similar effects to ANS drugs

 

SANS AND PANS ARE DIVISIONS OF ANS THAT BALANCE EACH OTHER OUT – IF THEY ARE NOT BALANCED THERE IS MEDICATION TO DO SO!!

 

PANS

PARASYMPATHETIC AUTONOMIC SYSTEM

q       CONSERVATION OF BODY PROCESSES

q       INFLUENCES DIGESTION AND INTESTINAL TRACT MOTILITY

q       PRINCIPLE MEDIATOR = ACETYLCHOLINE

q       NERVES THAT RELEASE ACETYLCHOLINE ARE = CHOLINERGIC

 

SANS

Sympathetic Autonomic Nervous System

q       Prepares for emergencies, FIGHT OR FLIGHT

q       Transmitters = NOREPINEPHRINE and EPINEPHRINE

q       Nerves that release them are = ADRENERGIC

 

* NUEROTRANSMITTERS  LOCATION

q       ACETYLCHOLINE= BETWEEN PREGANGLIONIC AND POSTGANGLIONIC NERVES IN PANS AND SANS

q       Norepinephrine = between postganglionic SYNAPSE AND EFFECTOR ORGAN IN SANS

 

SANS A-RECEPTOR

 

q       SKIN, SKELETAL MUSCLE

q       VASOCONSTRICTION OF BOTH

q       DRUGS THAT BLOCK ACTION AT A RECEPTOR ARE CALLED  A-ADRENERGIC BLOCKING AGENTS

 

SANS B-RECEPTOR

 

B1 AND B2

TYPE OF RECPTOR FOUND IN THE TISSUE DETERMINES THE EFFECT

q       B1 = WHEN EXCITED CAUSE STIMULATION OF HEART MUSCLE = INCREASED HEART RATE AND STRENGTH

q       B2= SMOOTH MUSCLE INHIBITION OR RELAXATION- VASODILATION, BROCHODILATION

q       EX:  ASTHMA MEDS WORK THIS WAY

 

ANY DRUG THAT BLOCKS B RECEPTORS IS CALLED  B ADRENERGIC BLOCKERS!!

 

DRUGS

q       ACT WHERE CHOLINE IS RELEASED = CHOLINERGIC

 

q       ACT WHERE NOREPINEHRINE IS RELEASED ARE = ADRENERGIC

 

q       ACT WHERE PANS IS LOCATED = PARASYMPATHO-

 

q       ACT WHERE SANS IS LOCATED = SYMPATHO-

 

q       ACT AT LOCATION WHERE ANS IS W/ SAME EFFECT = SUFFIX MIMETIC = AGONIST

 

q       OPPOSITE EFFECT = SUFFIX LYTIC OR BLOCKER

AKA ANTAGONIST

 

ANS DRUG CATEGORIES

q       P + PARASYMPATHOMIMETIC, CHOLINERGICS

( + = MIMETIC, CHOLINERGICS POSITIVE)

q       P – ANTICHOLINERGICS, PARASYMPATHOLYTICS

( - =  ANTI, NEGATIVE, LYTICS = AGAINST SO ITS NEGATIVE)

 

q       S + SYMPATHOMIMETIC, ADRENERGIC

( + = MIMETIC POSITIVE)

q       S – SYMPATHOLYTICS, ADRENERGIC BLOCKERS, SYMPATHETIC BLOCKERS

( - = NEGATIVE TO GO AGAINST “LYTIC”, OR TO BLOCK)

 

facts

 

q       cholinergics act on site where acetylcholine is released

q       ADRENERGIC ACT AT SITE WHERE EPI OR NOREPI IS RELEASED

q       PREFIXES PARA AND SYMP DENOTE = LOCATION WHERE DRUG ACTS

 

PANS

CHOLINERGICS AGENTS – PARASYMATHOMIMETIC

q       EFFECTS SIMILAR TO THOSE PRODUCED BY ACETYLCHOLINE

q       DIRECT ACTING DRUGS = DIRECTLY ON SITE = DECREASE HEART RATE

q       INDIRECT ACTING = ACT ON ENZYMES THAT NORMALLY INHIBIT ACETYLVHOLINE

q       EX: ACETYLCHOLINESTERASE, ACETYLCHOLINE IS NOT BROKEN DOWN, PANS IS STIMULATED

q       INCREASE HEART RATE OCCURES

q       RESULTING EFFECT = DEPENDS ON CONCENTRATION OF DRUG

 

CHOLINERGICS AGENTS USES

q       STIMULATE INTESTINE, BLADDER, POST OP

q       INCREASING PERISTALSIS AND URINATION

q       LOWER OCULAR PRESSURE

q       PROMOTE SALIVATION AND SWEATING

 

TREAT MYASTHENIA GRAVIS- AUTOIMMUNE DISEASE WHICH IS CHARICTERIZED BY FLUCTUATING SOMETIMES FATAL, MUSCLE WEAKNESS.  EXCESSIVE CHOLINERGIC BLOCKAGE

TREAT IT WITH

q       NEOSTIGMINE, PYRIDOSTIGMINE, AND AMBENONIUM

 

EFFECTS OF CHOLINERGIC AGENTS TO

CARDIOVASCULAR

q       DIRECT = DECREASE HEART OUT PUT, EFFECTS ON SMOOTH MUSCLE RESULT IN RELAXATION AND VASODILATION, LOWER BP, DECREASE IN PERIPHERAL RESISTANCE

 

q       INDIRECT – INCREASE IN HEART RATE AND CARDIAC INPUT

 

 

Effects of GI

q       Activate smooth muscle

q       Motility and secretion

 

Ocular

Intraocular pressure is decreased

 

Adverse reactions of cholinergic agents

q       Extensions of their pharmacologic effects

Slud

q       Salivation

q       Lacrimation

q       Urination

q       Defecation

q       W/ larger doses= paralysis can occur

q       Confusion ( cns)

 

Contraindications

q       Asthma – bronchial spasm may occur

q       Hyperthyroidism- may cause hypo= atrial fibrillation

q       Gi tract or urinary obstruction, motility

q       Severe cardiac disease

q       Myasthenia gravis being treated by – neostigmine

q       Treatment of Alzheimer’s

 

Effects of direct acting cholinergic agents specific drugs

q       Pilocarpine ( salagen) treats

Xerostomia

Glaucoma

Occasionally myasthenia gravis

 

Side effects

q       Sweating , nausea, rhinitis, chills and flushed skin

q       5 mg tabs, tid

q       ophthalmic solutions

 

pharm. Effects of indirect acting drugs

reversible

 

Physostigmine (antilirium) treats

q       toxicity- from anticholinergic agents (atropine, phenothiazines, tricyclic antidepressants and antihistamines)

 

irreversible acting drugs - warfare

parathion

malathion

sarin

 

Cholinergic crisis

q       excess accho in system, over dosage

q       pralidoxine treats

anticholinergic agents ( parasympatholytic p - )

q       prevents action of – acetylcholine at receptor site,

q       blocked competively by antagonists

q       block the action of acCho on smooth muscle of intestines heart and gland

q       aka muscarinic receptor blockers, do not block the nicotinic receptors

 

Uses

q       Preop-

q       Inhibit saliva and mucus that are stimulated by gen anes

q       Blocks clowing of the heart rate, general anesthesia

q       Treat GI disorders, to treat diarrhea

q       Dilate eye

q       Reduction of parkinsons

q       Motion sickness dentistry= to create a dry field

 

SUMMARY ANTICHOLINERGIC AGENTS

CNS

q       Higher doses – stimulate

q       Lower doses – depress

EXOCRINE GLANDS

q       Reduce flow or secretions9 dry field)

Smooth muscle

q       Relaxes smooth muscle in respiratory tract

q       Treatment of asthma

CV

q       Tachycardia- prevent cardiac slowing during general anesthesia( decreases activity of vagus nerve)

 

Adverse reactions = anticholinergic agents

q       Xerostomia

q       Photophobia- eye

q       Tachycardia

q       Fever

q       Urinary and GI stasis

q       Hot, dry, flushed skin from lack of sweating

 

TOXICITY

q       Atropine and scapolomine- excitation, hallucinations delirium, and profound CNS depression,  untreated can be fatal

q        

Phenothiazines= antidepressants

Antihistamines = zyrtec, benadryl

Tricylic antidepressants – TCA’s ( older meds)

 Click on the banners below